Oral contrast for abdominal and pelvic CT: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
*Pros: May add improved imaging characteristics for some patient groups | *Pros: May add improved imaging characteristics for some patient groups | ||
*Cons: Requires significant "lead time" (i.e. must administer >1hr prior to CT scan) and can result in delays to care | *Cons: Requires significant "lead time" (i.e. must administer >1hr prior to CT scan) and can result in delays to care | ||
==Indications== | |||
===Desirable=== | |||
*[[Appendicitis]] or [[Diverticulitis]] with BMI <20 | |||
**if CT indicated; consider immediate surgical consultation | |||
*Suspected fistula or bowel leak | |||
*Suspected [[Intussusception]] or internal hernia | |||
===Consider=== | |||
*Suspected low-grade [[bowel obstruction]] | |||
*Intra-abdominal [[abscess]] depending on the suspected primary source | |||
**May not be required if primary source is skin infection | |||
*Metastatic evaluation | |||
*Suspected [[Hernia]] | |||
===Not Indicated=== | |||
*Emergent process needing immediate CT | |||
*Delays in time to imaging due to prolonged intolerance of oral contrast | |||
*Uncomplicated [[Appendicitis]] or [[Diverticulitis]] with BMI >20 | |||
*Suspected high-grade or severe [[bowel obstruction]] | |||
*Suspected aneurysm, dissection, or vessel thrombosis | |||
*Suspected bowel ischemia or infarct | |||
*[[Nephrolithiasis]] protocol | |||
*Pancreatic protocol for [[Pancreatitis]] or mass | |||
*Liver protocol for liver mass or abscess | |||
*Adrenal protocol for adrenal mass or nodules | |||
*Superficial abdominal wall infections or abscesses | |||
*[[Inflammatory bowel disease]] | |||
==Redypaque Dose== | ==Redypaque Dose== | ||
| Line 89: | Line 119: | ||
Max = 300cc | Max = 300cc | ||
==See Also== | ==See Also== | ||
Revision as of 18:49, 26 June 2018
Background
- Oral contrast considerations for patients undergoing CT of abdomen and/or pelvis
- Pros: May add improved imaging characteristics for some patient groups
- Cons: Requires significant "lead time" (i.e. must administer >1hr prior to CT scan) and can result in delays to care
Indications
Desirable
- Appendicitis or Diverticulitis with BMI <20
- if CT indicated; consider immediate surgical consultation
- Suspected fistula or bowel leak
- Suspected Intussusception or internal hernia
Consider
- Suspected low-grade bowel obstruction
- Intra-abdominal abscess depending on the suspected primary source
- May not be required if primary source is skin infection
- Metastatic evaluation
- Suspected Hernia
Not Indicated
- Emergent process needing immediate CT
- Delays in time to imaging due to prolonged intolerance of oral contrast
- Uncomplicated Appendicitis or Diverticulitis with BMI >20
- Suspected high-grade or severe bowel obstruction
- Suspected aneurysm, dissection, or vessel thrombosis
- Suspected bowel ischemia or infarct
- Nephrolithiasis protocol
- Pancreatic protocol for Pancreatitis or mass
- Liver protocol for liver mass or abscess
- Adrenal protocol for adrenal mass or nodules
- Superficial abdominal wall infections or abscesses
- Inflammatory bowel disease
Redypaque Dose
|
Weight |
Give 1 hour prior to scan |
Give 30 minutes prior to scan |
Give immediately upon arrival to CT |
|
< 2 kg |
None or as ordered by physician |
None or as ordered by physician |
None or as ordered by physician |
|
2-5 kg |
30 mL |
30 mL |
30 mL |
|
>5-20 kg |
90 mL |
90 mL |
90 mL |
|
>20-50 kg |
150 mL |
150 mL |
150 mL |
|
>50 kg |
300 mL |
300 mL |
300 mL |
(100cc/age)/3 = dose x 3
Max = 300cc
